<PAGE>
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 27, 1999
MEDICAL TECHNOLOGY SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-16594 59-2740462
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
12920 Automobile Boulevard, Clearwater, Florida 37622
-----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (727) 576-6311
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
2
This document and the accompanying exhibit contain statements that
constitute "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities and
Exchange Act of 1934, as amended. The words "believe", "estimate", "expect",
"intend", "anticipate" and similar expressions and variations thereof identify
certain of such forward-looking statements, which speak only as of the dates on
which they were made. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise. Readers are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those
indicated in the forward-looking statements as a result of various factors.
Readers are cautioned not to place undue reliance on these forward-looking
statements.
Item 5. Other Events
Medical Technology Systems, Inc. (the "Company") has outstanding 1,320,000
warrants (the "Warrants"), each of which is exercisable to purchase one share of
the Company's common stock for $7.00. The Warrants are callable by the Company,
upon 30 days written notice, for $0.05 per Warrant. Originally, the Warrants
were scheduled to expire on July 17, 1999. On July 16, 1999, the Company
extended the expiration date from July 17, 1999 to July 17, 2000. On June 15,
1998, the Company extended the expiration date of the Warrants from July 17,
1998 to July 17, 1999. All other conditions of the Warrants remain the same.
Item 7. Financial Statements and Exhibits
(A)Exhibits.
4.1 Form of Second Amendment to Warrant Agreement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 16, 1999
MEDICAL TECHNOLOGY SYSTEMS, INC.
(Registrant)
By: /s/ Michael P. Conroy
-------------------------------------------
Michael P. Conroy
Vice President and Chief Financial Officer
<PAGE>
3
EXHIBIT INDEX
MEDICAL TECHNOLOGY SYSTEMS, INC.
Current Report on Form 8-K
Dated: July 16, 1999
EXHIBIT NO. DESCRIPTION
- ------------------------ ---------------------------------------------
4.1 Form of Fourth Amendment to Warrant Agreement
FOURTH AMENDMENT TO WARRANT AGREEMENT
This Fourth Amendment to Warrant Agreement (the "Fourth Amendment") is
effective as of this 14th day of July, 1999, by and between Medical Technology
Systems, Inc., a Delaware corporation (the "Company"), and Continental Stock
Transfer & Trust Company, as Warrant Agent (the "Warrant Agent").
BACKGROUND
The Company originally entered into a Warrant Agreement with the Warrant
Agent in connection with a public offering of the Company's securities pursuant
to a prospectus dated July 17, 1991. On June 15, 1998, the parties executed the
Third Amendment to Warrant Agreement (the "Amendment") that extended to July 17,
1999 from July 17, 1998 the expiration date of the warrants to purchase shares
of the Company's common stock (the "Warrants"). The parties desire to amend the
Warrant Agreement and the Amendment for purposes of further extending the
expiration date of the Warrants.
Therefore, for good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the parties agree as follows:
TERMS
1. Expiration Date of Warrants. The Warrant Expiration Date is hereby
extended to July 17, 2000 from July 17, 1999.
2. No Other Effect. Except as specifically set forth above, this instrument
shall not affect the rights of the parties under the Warrant Agreement or the
Amendment.
3. Counterparts, Amendment, and Construction. This instrument: (a) may be
executed in two or more counterparts, each of which shall be deemed an original,
and all of which together shall constitute one instrument; (b) cannot be
amended, modified, or supplemented in any respect except by a subsequent written
agreement entered into by all the parties to this Fourth Amendment; and (c)
shall be construed and enforced in accordance with the laws of Florida.
IN WITNESS WHEREOF, the parties have executed this Fourth Amendment
effective as of the date first written above.
MEDICAL TECHNOLOGY SYSTEMS, INC.
By: ___________________________________
Michael P. Conroy, Vice President
and Chief Financial Officer
CONTINENTAL STOCK TRANSFER & TRUST COMPANY
By: __________________________________
Authorized Officer
